bluebird bio: Bluebird Draws Another Suitor Amid Plans to Go Private
Ayrmid's offer is 50% higher than bluebird's previously announced deal with Carlyle and SK Capital Partners.
Read full article »
bluebird bio is a Massachusetts-based biotechnology company that researches and develops gene therapies for the treatment of genetic diseases.
Read more